SCHEMBL7991565

SCHEMBL7991565

CCC(=O)Nc1ncn(Cc2ccccc2)c1C(N)=O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.49
GAA P10253 2/20 0.49
PKM P14618 1/20 0.49
KMT2A Q03164 1/20 0.47
SMN1; SMN2 Q16637 2/20 0.44
LMNA P02545 2/20 0.44
FGFR1 P11362 1/20 0.43
FGFR4 P22455 1/20 0.43
ALDH1A1 P00352 6/20 0.42
KDM4E B2RXH2 5/20 0.42
HSD17B10 Q99714 2/20 0.42
MAPK1 P28482 1/20 0.42
HTT P42858 1/20 0.42
ADRA1D P25100 1/20 0.41
MMP13 P45452 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
PDE4A P27815 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7988641 0.93 KMT2A (0.44) TSHRGAAPKMKMT2ASMN1; SMN2
SCHEMBL7974223 0.90 RAB9A (0.46) GAASMN1; SMN2ALDH1A1HTTL3MBTL1
SCHEMBL7987555 0.90 GAA (0.47) TSHRGAAPKMKMT2AALDH1A1
SCHEMBL7973987 0.89 FGFR1 (0.45) TSHRGAAPKMKMT2ASMN1; SMN2
SCHEMBL7987930 0.89 KMT2A (0.57) KMT2ASMN1; SMN2LMNAALDH1A1KDM4E
SCHEMBL7974162 0.89 KDM4E (0.52) KMT2ASMN1; SMN2FGFR1FGFR4ALDH1A1
SCHEMBL7991550 0.88 GAA (0.45) TSHRGAAPKMALDH1A1HTT
SCHEMBL7985832 0.88 TSHR (0.47) TSHRGAAPKMSMN1; SMN2LMNA
SCHEMBL7987961 0.87 MAPT (0.47) PKMKMT2ALMNAALDH1A1ADRA1D
SCHEMBL7987935 0.87 XDH (0.47) TSHRGAAPKMKMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed